BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26015192)

  • 1. [Heart risk due to testosterone?].
    Grätzel P
    MMW Fortschr Med; 2015 Apr; 157(6):27. PubMed ID: 26015192
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke.
    Seftel AD
    J Urol; 2015 Sep; 194(3):759-60. PubMed ID: 26292880
    [No Abstract]   [Full Text] [Related]  

  • 3. Testosterone: myocardial infarction and stroke.
    Prescrire Int; 2014 Oct; 23(153):240-1. PubMed ID: 25964971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone replacement therapy faces FDA scrutiny.
    Garnick MB
    JAMA; 2015 Feb; 313(6):563-4. PubMed ID: 25502018
    [No Abstract]   [Full Text] [Related]  

  • 5. [Testosterone supplementation: good feeling in the pants, pain in the chest].
    Einecke D
    MMW Fortschr Med; 2014 Mar; 156(4):22. PubMed ID: 24908760
    [No Abstract]   [Full Text] [Related]  

  • 6. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The testosterone storm.
    Gomella LG
    Can J Urol; 2015 Apr; 22(2):7677. PubMed ID: 25891328
    [No Abstract]   [Full Text] [Related]  

  • 8. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Joint meeting for Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSARM AC), September 17, 2014.
    Seftel AD
    J Urol; 2015 Feb; 193(2):623-5. PubMed ID: 25617291
    [No Abstract]   [Full Text] [Related]  

  • 10. Testosterone and cardiovascular disease.
    Schooling CM
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):202-8. PubMed ID: 24722171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversy over Cardiovascular Risks of Testosterone Therapy.
    Carter D
    Am J Nurs; 2015 May; 115(5):17. PubMed ID: 25906216
    [No Abstract]   [Full Text] [Related]  

  • 12. A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury.
    Bauman WA; Cirnigliaro CM; La Fountaine MF; Jensen AM; Wecht JM; Kirshblum SC; Spungen AM
    Horm Metab Res; 2011 Jul; 43(8):574-9. PubMed ID: 21717386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
    Tripathy D; Shah P; Lakshmy R; Reddy KS
    Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: risk of myocardial infarction in older men receiving testosterone therapy.
    Dohle GR; Dinkelman-Smit M
    Eur Urol; 2015 Oct; 68(4):739-40. PubMed ID: 26334123
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage.
    Everhart A; Harper K; Jeffery MM; Levin Z; Morden NE; Sankar A; Karaca-Mandic P
    JAMA Netw Open; 2021 Sep; 4(9):e2127349. PubMed ID: 34586370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK.
    Goodman N; Guay A; Dandona P; Dhindsa S; Faiman C; Cunningham GR;
    Endocr Pract; 2015 Sep; 21(9):1066-73. PubMed ID: 26355962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy. More risk than benefit?
    Harv Health Lett; 2000 Jun; 25(8):4-5. PubMed ID: 10810049
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between cholesterol gallstones and testosterone replacement therapy in a patient with primary hypogonadism.
    Squarza S; Rossi UG; Torcia P; Cariati M
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(2):205-207. PubMed ID: 29656844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.